| Field | Row 1 |
|---|---|
| adsh | 0001213900-25-044197 |
| cik | 2020385 |
| name | TAVIA ACQUISITION CORP. |
| sic | 6770 |
| countryba | US |
| stprba | DE |
| cityba | NEWARK |
| zipba | 19711 |
| bas1 | 850 LIBRARY AVENUE |
| bas2 | SUITE 204 |
| baph | 212-506-6298 |
| countryma | US |
| stprma | DE |
| cityma | NEWARK |
| zipma | 19711 |
| mas1 | 850 LIBRARY AVENUE |
| mas2 | SUITE 204 |
| countryinc | KY |
| stprinc | |
| ein | 000000000 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 16:07:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ea0242201-10q_tavia_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-044197 | 20250331 | Additional Paid In Capital | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Accrued Offering Costs Current | 85000.0000 | USD | 0 | 0001213900-25-044197 | |||
| 0001213900-25-044197 | 20241231 | Assets Current | 957718.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Common Stock Shares Issued | 4420833.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20241231 | Common Stock Shares Outstanding | 4420833.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20250331 | Costs And Expenses Related Party | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20240331 | Earnings Per Share Basic | -0.0100 | USD | 0 | us-gaap/2025 | Class Of Stock= Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20250331 | Earnings Per Share Basic | 0.0600 | USD | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20240331 | Increase Decrease In Prepaid Expense | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20240331 | Net Income Loss | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-044197 | 20240331 | Operating Income Loss | -40541.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Payment Of Formation Costs Through Promissory Note | 3027.0000 | USD | 0 | 0001213900-25-044197 | |||
| 0001213900-25-044197 | 20250331 | Preferred Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20250331 | Prepaid Expense Current | 122506.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240229 | Stockholders Equity | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20250331 | Stockholders Equity | -72805.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Stockholders Equity | 442.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Value Other | 722000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Temporary Equity Shares Outstanding | 11500000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 913659.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Common Stock Shares Issued | 4420833.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Common Stock Shares Outstanding | 4420833.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Earnings Per Share Diluted | -0.0100 | USD | 0 | us-gaap/2025 | Class Of Stock= Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20240331 | Fair Value Of E B C Founder Shares Charged To Deferred Offering Costs And Other Assets | 722000.0000 | USD | 0 | 0001213900-25-044197 | |||
| 0001213900-25-044197 | 20250331 | Increase Decrease In Prepaid Expense | 78447.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Net Cash Provided By Used In Operating Activities | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20240331 | Nonoperating Income Expense | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Other Notes Payable Current | 500000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-044197 | 20241231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20240229 | Shares Outstanding | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-044197 | 20240331 | Stockholders Equity | 706459.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Stockholders Equity | -40541.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044197 | 20241231 | Stockholders Equity | 329697.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044197 | 20250331 | Stockholders Equity | -73247.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044197 | 20250331 | Temporary Equity Accretion To Redemption Value | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-044197 | 20240331 | Weighted Average Number Of Shares Issued Basic | 4575000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20250331 | Accrued Liabilities Current | 144257.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Accrued Offering Costs Current | 75000.0000 | USD | 0 | 0001213900-25-044197 | |||
| 0001213900-25-044197 | 20250331 | Assets Held In Trust Noncurrent | 117142639.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Common Stock Shares Authorized | 400000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Common Stock Shares Issued | 4420833.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20240331 | Costs And Expenses Related Party | 5000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Earnings Per Share Diluted | 0.0600 | USD | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20250331 | Earnings Per Share Diluted | 0.0600 | USD | 1 | us-gaap/2025 | Class Of Stock= Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20250331 | Fair Value Of E B C Founder Shares Charged To Deferred Offering Costs And Other Assets | USD | 1 | 0001213900-25-044197 | ||||
| 0001213900-25-044197 | 20240331 | Increase Decrease In Accrued Liabilities | 32514.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Liabilities And Stockholders Equity | 117920775.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Prepaid Expense Current | 44059.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240229 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-044197 | 20240229 | Stock Issued During Period Shares New Issues | 200000.0000 | shares | 0 | us-gaap/2025 | Related Party Transactions By Related Party= E B C Founder Shares; | ||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Value Other | 721980.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044197 | 20241130 | Stock Issued During Period Value Other | 115000000.0000 | USD | 0 | us-gaap/2025 | Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-044197 | 20250331 | Temporary Equity Redemption Price Per Share | 10.1900 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 4575000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20241231 | Accrued Liabilities Current | 72448.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Assets | 116884655.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -258029.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Common Stock Shares Outstanding | 37500.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001213900-25-044197 | 20250331 | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | USD | 1 | 0001213900-25-044197 | ||||
| 0001213900-25-044197 | 20240331 | General And Administrative Expense | 40541.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Investment Income Interest | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Liabilities | 789132.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Liabilities | 850941.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Net Cash Provided By Used In Financing Activities | -10000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Net Income Loss | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-044197 | 20250331 | Other Liabilities Current | 131684.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-044197 | 20240331 | Payments Of Stock Issuance Costs | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Preferred Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Stockholders Equity | 442.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20241231 | Stockholders Equity | 79518.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044197 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Shares New Issues | 5031250.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Value New Issues | 24497.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Value Other | 20.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20250331 | Temporary Equity Accretion To Redemption Value | 1456773.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Assets Current | 778136.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Assets Held In Trust Noncurrent | 117142639.0000 | USD | 0 | us-gaap/2025 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001213900-25-044197 | 20241231 | Common Stock Value | 442.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | General And Administrative Expense | 241391.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Net Cash Provided By Used In Operating Activities | -248029.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Nonoperating Income Expense | 1215702.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Operating Income Loss | -241391.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Payments Of Stock Issuance Costs | 10000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20240229 | Stock Issued During Period Shares Other | 150000.0000 | shares | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Founder Shares; | ||
| 0001213900-25-044197 | 20240229 | Stock Issued During Period Shares Other | 50000.0000 | shares | 0 | us-gaap/2025 | Title Of Individual= Director Nominees; | ||
| 0001213900-25-044197 | 20241231 | Temporary Equity Accretion To Redemption Value | 5586528.0000 | USD | 4 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Assets Held In Trust Noncurrent | 115926937.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240229 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Common Stock Value | 442.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Investment Income Interest | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20240331 | Net Income Loss | -40541.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044197 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-044197 | 20250331 | Net Income Loss | 974311.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044197 | 20240331 | Offering Costs Included In Accrued Offering Costs | 137631.0000 | USD | 0 | 0001213900-25-044197 | |||
| 0001213900-25-044197 | 20241231 | Shares Outstanding | 4420833.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20240229 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-044197 | 20241231 | Stockholders Equity | 409657.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Shares Other | 200000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20241130 | Stock Issued During Period Shares Other | 11500000.0000 | shares | 0 | us-gaap/2025 | Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-044197 | 20250331 | Stock Issued During Period Shares Other | 11500000.0000 | shares | 1 | us-gaap/2025 | Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-044197 | 20240229 | Stock Issued During Period Value New Issues | 994.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= E B C Founder Shares; | ||
| 0001213900-25-044197 | 20240229 | Stock Issued During Period Value Other | 750.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Founder Shares; | ||
| 0001213900-25-044197 | 20250331 | Temporary Equity Accretion To Redemption Value | 329697.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044197 | 20250331 | Weighted Average Number Of Shares Issued Basic | 11500000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20250331 | Assets | 117920775.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Additional Paid In Capital | 329697.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Assets Held In Trust Noncurrent | 115926937.0000 | USD | 0 | us-gaap/2025 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
| 0001213900-25-044197 | 20250331 | Common Stock Shares Authorized | 400000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Common Stock Shares Outstanding | 4420833.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20240331 | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 20000.0000 | USD | 0 | 0001213900-25-044197 | |||
| 0001213900-25-044197 | 20250331 | Earnings Per Share Basic | 0.0600 | USD | 1 | us-gaap/2025 | Class Of Stock= Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-044197 | 20240331 | Shares Outstanding | 5231250.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20240229 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Value New Issues | 25000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Value New Issues | 503.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20250331 | Temporary Equity Accretion To Redemption Value | 1127076.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-044197 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 115685866.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Temporary Equity Carrying Amount Attributable To Parent | 117142639.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Temporary Equity Redemption Price Per Share | 10.0600 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Temporary Equity Shares Outstanding | 11500000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 4420833.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 11500000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Redeemable Ordinary Shares; | ||
| 0001213900-25-044197 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 655630.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Common Stock Shares Issued | 4420833.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Common Stock Shares Outstanding | 4420833.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Increase Decrease In Accrued Liabilities | 71809.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Investment Income Interest | 1215702.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Liabilities And Stockholders Equity | 116884655.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20240331 | Net Cash Provided By Used In Financing Activities | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-044197 | 20240331 | Net Income Loss | -40541.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Net Income Loss | 974311.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Offering Costs Included In Accrued Offering Costs | USD | 1 | 0001213900-25-044197 | ||||
| 0001213900-25-044197 | 20241231 | Other Liabilities Current | 131684.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-044197 | 20250331 | Other Notes Payable Current | 500000.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-044197 | 20250331 | Payment Of Formation Costs Through Promissory Note | USD | 1 | 0001213900-25-044197 | ||||
| 0001213900-25-044197 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20241231 | Retained Earnings Accumulated Deficit | 79518.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Retained Earnings Accumulated Deficit | -73247.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-044197 | 20250331 | Shares Outstanding | 4420833.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20240331 | Stockholders Equity | 746477.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-044197 | 20240331 | Stockholders Equity | 523.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-044197 | 20240331 | Stock Issued During Period Value New Issues | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-044197 | 20250331 | Weighted Average Number Of Shares Issued Basic | 4420833.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Ordinary Shares; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Temporary Equity Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Temporary Equity, Shares Outstanding | The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Temporary Equity Accretion To Redemption Value | us-gaap/2025 | 0 | 0 | monetary | D | C | Temporary Equity, Accretion to Redemption Value | Value of accretion of temporary equity to its redemption value during the period. |
| Other Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Investment Income Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Stock Issued During Period Shares Other | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | |
| Temporary Equity Redemption Price Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Temporary Equity, Redemption Price Per Share | Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Accrued Offering Costs Current | 0001213900-25-044197 | 1 | 0 | monetary | I | C | Accrued Offering Costs Current | Amount of accrued offering costs classified as current. |
| Payment Of Formation Costs Through Promissory Note | 0001213900-25-044197 | 1 | 0 | monetary | D | D | Payment Of Formation Costs Through Promissory Note | Amount of payment of formation costs through promissory note. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation | Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Prepaid Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. |
| Other Notes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Notes Payable, Current | Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Payments Of Stock Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Stock Issued During Period Value Other | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. |
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001213900-25-044197 | 1 | 0 | monetary | D | C | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class BOrdinary Shares | Amount deferred offering costs paid by Sponsor in exchange for issuance of ordinary shares. |
| Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2025 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Attributable to Parent | Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Assets Held In Trust Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Asset, Held-in-Trust, Noncurrent | The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited. |
| Weighted Average Number Of Shares Issued Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Issued, Basic | This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic). | |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Offering Costs Included In Accrued Offering Costs | 0001213900-25-044197 | 1 | 0 | monetary | D | C | Offering Costs Included In Accrued Offering Costs | Amount of offering costs included in accrued offering costs. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Costs And Expenses Related Party | us-gaap/2025 | 0 | 0 | monetary | D | D | Costs and Expenses, Related Party | Costs of sales and operating expenses for the period incurred from transactions with related parties. |
| Increase Decrease In Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Prepaid Expense Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Fair Value Of E B C Founder Shares Charged To Deferred Offering Costs And Other Assets | 0001213900-25-044197 | 1 | 0 | monetary | D | C | Fair Value Of EBCFounder Shares Charged To Deferred Offering Costs And Other Assets | The amount of fair value of EBC Founder Shares charged to deferred offering costs and other assets. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-044197 | 2 | 8 | BS | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash | 0 |
| 0001213900-25-044197 | 2 | 9 | BS | 0 | H | Prepaid Expense Current | us-gaap/2025 | Prepaid expenses | 0 |
| 0001213900-25-044197 | 2 | 10 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001213900-25-044197 | 2 | 11 | BS | 0 | H | Assets Held In Trust Noncurrent | us-gaap/2025 | Marketable securities held in Trust Account | 0 |
| 0001213900-25-044197 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2025 | TOTAL ASSETS | 0 |
| 0001213900-25-044197 | 2 | 15 | BS | 0 | H | Accrued Offering Costs Current | 0001213900-25-044197 | Accrued offering costs | 0 |
| 0001213900-25-044197 | 2 | 16 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-044197 | 2 | 17 | BS | 0 | H | Other Liabilities Current | us-gaap/2025 | Advances from related party | 0 |
| 0001213900-25-044197 | 2 | 18 | BS | 0 | H | Other Notes Payable Current | us-gaap/2025 | Promissory note related party | 0 |
| 0001213900-25-044197 | 2 | 19 | BS | 0 | H | Liabilities | us-gaap/2025 | TOTAL LIABILITIES | 0 |
| 0001213900-25-044197 | 2 | 20 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | COMMITMENTS AND CONTINGENCIES (Note 6) | 0 |
| 0001213900-25-044197 | 2 | 21 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2025 | Ordinary shares subject to possible redemption, 11,500,000 shares at redemption value of approximately $10.19 and $10.06 per share as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001213900-25-044197 | 2 | 23 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preferred shares, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding | 0 |
| 0001213900-25-044197 | 2 | 24 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 4,420,833 shares issued and outstanding (excluding 11,500,000 subject to possible redemption) as of March 31, 2025 and December 31, 2024 | 0 |
| 0001213900-25-044197 | 2 | 25 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-044197 | 2 | 26 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Retained earnings (accumulated deficit) | 0 |
| 0001213900-25-044197 | 2 | 27 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | TOTAL SHAREHOLDERS EQUITY (DEFICIT) | 0 |
| 0001213900-25-044197 | 2 | 28 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | TOTAL LIABILITIES AND SHAREHOLDERS EQUITY (DEFICIT) | 0 |
| 0001213900-25-044197 | 3 | 1 | BS | 1 | H | Temporary Equity Shares Outstanding | us-gaap/2025 | Ordinary shares subject to possible redemption shares | 0 |
| 0001213900-25-044197 | 3 | 2 | BS | 1 | H | Temporary Equity Redemption Price Per Share | us-gaap/2025 | Ordinary shares subject to possible redemption, per share value (in Dollars per share) | 0 |
| 0001213900-25-044197 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred shares, shares par value (in Dollars per share) | 0 |
| 0001213900-25-044197 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred shares, shares authorized | 0 |
| 0001213900-25-044197 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred shares, shares issued | 0 |
| 0001213900-25-044197 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred shares, shares outstanding | 0 |
| 0001213900-25-044197 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Ordinary shares, shares par value (in Dollars per share) | 0 |
| 0001213900-25-044197 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Ordinary shares, shares authorized | 0 |
| 0001213900-25-044197 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Ordinary shares, shares issued | 0 |
| 0001213900-25-044197 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Ordinary shares, shares outstanding | 0 |
| 0001213900-25-044197 | 4 | 7 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative costs | 0 |
| 0001213900-25-044197 | 4 | 8 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operations | 0 |
| 0001213900-25-044197 | 4 | 10 | IS | 0 | H | Investment Income Interest | us-gaap/2025 | Interest earned on marketable securities held in Trust Account | 0 |
| 0001213900-25-044197 | 4 | 11 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total other income | 0 |
| 0001213900-25-044197 | 4 | 12 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net income (loss) | 0 |
| 0001213900-25-044197 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Shares Issued Basic | us-gaap/2025 | Basic weighted average shares outstanding (in Shares) | 0 |
| 0001213900-25-044197 | 4 | 14 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Diluted weighted average shares outstanding (in Shares) | 0 |
| 0001213900-25-044197 | 4 | 15 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic net income (in Dollars per share) | 0 |
| 0001213900-25-044197 | 4 | 16 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Diluted net income (in Dollars per share) | 0 |
| 0001213900-25-044197 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-044197 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-044197 | 5 | 10 | EQ | 0 | H | Temporary Equity Accretion To Redemption Value | us-gaap/2025 | Accretion for ordinary shares to redemption amount | 1 |
| 0001213900-25-044197 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Issuance of ordinary shares to Sponsor | 0 |
| 0001213900-25-044197 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Issuance of ordinary shares to Sponsor (in Shares) | 0 |
| 0001213900-25-044197 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2025 | Issuance of ordinary shares to underwriters | 0 |
| 0001213900-25-044197 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Shares Other | us-gaap/2025 | Issuance of ordinary shares to underwriters (in Shares) | 0 |
| 0001213900-25-044197 | 5 | 15 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net income (Loss) | 0 |
| 0001213900-25-044197 | 5 | 16 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-044197 | 5 | 17 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-044197 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net income (loss) | 0 |
| 0001213900-25-044197 | 6 | 4 | CF | 0 | H | Costs And Expenses Related Party | us-gaap/2025 | Payment of formation costs through issuance of founder shares | 0 |
| 0001213900-25-044197 | 6 | 5 | CF | 0 | H | Payment Of Formation Costs Through Promissory Note | 0001213900-25-044197 | Payment of formation costs through promissory note | 0 |
| 0001213900-25-044197 | 6 | 6 | CF | 0 | H | Investment Income Interest | us-gaap/2025 | Interest earned on marketable securities held in Trust Account | 1 |
| 0001213900-25-044197 | 6 | 8 | CF | 0 | H | Increase Decrease In Prepaid Expense | us-gaap/2025 | Prepaid expenses | 1 |
| 0001213900-25-044197 | 6 | 9 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-044197 | 6 | 10 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001213900-25-044197 | 6 | 12 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2025 | Payment of offering costs | 1 |
| 0001213900-25-044197 | 6 | 13 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash used in financing activities | 0 |
| 0001213900-25-044197 | 6 | 14 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | Net Change in Cash | 0 |
| 0001213900-25-044197 | 6 | 15 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash Beginning of period | 0 |
| 0001213900-25-044197 | 6 | 16 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash End of period | 0 |
| 0001213900-25-044197 | 6 | 18 | CF | 0 | H | Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 0001213900-25-044197 | Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | 0 |
| 0001213900-25-044197 | 6 | 19 | CF | 0 | H | Offering Costs Included In Accrued Offering Costs | 0001213900-25-044197 | Deferred offering costs included in accrued offering costs | 0 |
| 0001213900-25-044197 | 6 | 20 | CF | 0 | H | Fair Value Of E B C Founder Shares Charged To Deferred Offering Costs And Other Assets | 0001213900-25-044197 | Fair value of EBC Founder Shares charged to deferred offering costs and other assets | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |